| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_316fbdc884964f5cd336c7405437b8d6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d75bc08221a89bb3bf2d668bf159a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43055551d490fd162caf90e988808ff3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968796c12acc1011b5812e4660c37b1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_554b47f75c75fc21ebce5125797162db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b106a20111b5a6c3e0bd2b31b0166a |
| publicationDate |
2012-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120094473-A |
| titleOfInvention |
Oral Suspension Formulation of Eslicarbazepine Acetate |
| abstract |
An oral suspension formulation comprising eslicarbazepine acetate and a pharmaceutically acceptable liquid vehicle. |
| priorityDate |
2009-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |